Test Price
2,800 AED✅ Home Collection Available
DOCK8 Gene Mental Retardation, Autosomal Dominant Type 2 Genetic Test in UAE | AED 2,800 | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139). Next-Generation Sequencing with clinically validated bioinformatics pipeline.
Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. Samples transported under strict temperature control to our DHA-licensed facility in Dubai Healthcare City.
Clinical Guidance
Telephonic Post-Test Clinical Guidance in result interpretation by a certified genetic counsellor. A dedicated clinical team ensures you understand the implications of your result and the next steps in your care pathway.
Insurance & Billing
Direct Billing Verification via WhatsApp +971 54 548 8731. We work with all major UAE insurance networks to simplify the pre‑authorisation process.
Clinical Expertise
Supervised by Consultant Medical Geneticist with DHA registration ID 9294403. Report issuance includes comprehensive variant interpretation per ACMG guidelines.
Turnaround Time
3–4 weeks from sample receipt to final report. Expedited options available upon request.
Sample Collection
Whole Blood (EDTA), Extracted DNA, or One Drop Blood on FTA Card. All matrices validated for NGS.
Test Overview & Methodology
The DOCK8 Gene Mental Retardation, Autosomal Dominant Type 2 Genetic Test detects pathogenic variants in the DOCK8 gene linked to autosomal dominant intellectual disability type 2 (MRD2). This test uses Next-Generation Sequencing (NGS) covering all coding exons and flanking intronic regions with a minimum depth of 100x, ensuring high sensitivity for single nucleotide variants and small indels.
| Feature | Our Test – UAE Premier | Closest Alternative |
|---|---|---|
| Precision & Methodology | NGS with 99.9% sensitivity, ISO 9001:2015 certified, full DHA lab licence (1143) | Sanger sequencing only (lower coverage), foreign lab with uncertain accreditation |
| Turnaround Time | 3–4 weeks | 6–10 weeks (overseas shipment delays) |
| Pre‑test Requirements | Clinical history + genetic counselling session (pedigree chart) | Often no local counselling support |
| Sample Types | Whole Blood, Extracted DNA, or One Drop Blood on FTA Card | Limited to whole blood |
| Compliance & Data Protection | Federal Decree-Law No. 45 of 2021 (PDPL), Federal Law No. 2 of 2019 on ICT in Health, full DHA oversight | Varies, often non‑UAE jurisdiction |
Physician Insight & Safety Protocols
“Genetic testing for intellectual disability is a critical step toward precision medicine. The DOCK8 gene analysis provides families with a definitive molecular diagnosis, guiding prognosis and recurrence risk counselling. It must always be performed in conjunction with expert genetic counselling and a thorough clinical evaluation.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication & Treatment Continuity
Medication Warning
Do not discontinue any prescribed medication without consulting your treating physician. Genetic test results influence treatment decisions only in conjunction with a full clinical picture.
Exclusion Criteria & Red Flags
- Patients with acute febrile illness or active infection should postpone collection until recovery.
- This test is not intended as a stand-alone diagnostic tool; genetic counselling is mandatory before and after testing.
- If you experience severe psychological distress or crisis after receiving genetic information, seek immediate psychiatric support or call the UAE mental health hotline.
- Minors must be accompanied by a legal guardian, and consent must comply with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- In case of a suspected genetic emergency (e.g., rapid neurological decline), proceed directly to the nearest emergency department; do not wait for test results.
Patient FAQ & Clinical Guidance
1. What is the purpose of the DOCK8 gene mental retardation autosomal dominant type 2 test?
This NGS test identifies pathogenic DOCK8 gene variants causing autosomal dominant intellectual disability, enabling precise diagnosis and family risk assessment in as little as 3 weeks. It is indicated for individuals with unexplained intellectual disability, developmental delay, or a family history suggestive of autosomal dominant inheritance.
2. How should I prepare for the test and who needs a genetic counselling session beforehand?
A pre‑test genetic counselling session is mandatory; you will provide clinical history and a family pedigree chart to ensure accurate interpretation of sequencing data. The counsellor will discuss the benefits, limitations, and possible outcomes of the test. Post‑test counselling is also provided to help you understand the results.
3. What happens after I receive the result and will I get telephonic clinical guidance?
Our DHA‑licensed consultant medical geneticist or genetic counsellor provides a post‑test telephonic session, explaining the clinical meaning of the variant and recommending next management steps. This service is included in the test cost and can be scheduled at your convenience.
UAE Regulatory & Data Privacy Adherence
Your Data and Health Information Are Protected
DNA Labs UAE operates in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability
- Dubai Healthcare City Authority regulations
All genetic data is encrypted, stored within UAE servers, and accessed only by authorised clinical staff. Your consent is obtained prior to testing, and you have the right to request data deletion in accordance with PDPL.
Clinical & Logistical Metadata
| Test Name | DOCK8 Gene Mental Retardation, Autosomal Dominant Type 2 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) – whole coding region plus flanking introns |
| ICD-10-CM Code | Q87.8 (Other specified congenital malformation syndromes) |
| LOINC Code | 31208-2 (Sequencing of gene panel) |
| DHA Facility License & Laboratory Address | DHA License Number 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians